Skip to content

Drug interactions

Ipratropium-salbutamol + Prochlorperazine

Severity: Minor

Ipratropium-salbutamol and Prochlorperazine: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Prochlorperazine has anticholinergic activity and can prolong QT, and salbutamol at high doses can add to QT risk through hypokalemia. Inhaled ipratropium has low systemic exposure, so the additive anticholinergic effect is small.

What this interaction means in plain words

Ipratropium-salbutamol and Prochlorperazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Ipratropium-salbutamol belongs to Respiratory; Prochlorperazine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Weak additive anticholinergic effects and possible additive QT effects.

What to do

No routine changes needed; monitor ECG and potassium if high-dose salbutamol is used or other QT risk factors exist.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Prochlorperazine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ipratropium-salbutamol with Prochlorperazine?

MediHelp rates the interaction as minor. Ipratropium-salbutamol and Prochlorperazine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Prochlorperazine has anticholinergic activity and can prolong QT, and salbutamol at high doses can add to QT risk through hypokalemia. Inhaled ipratropium has low systemic exposure, so the additive anticholinergic effect is small.

How serious is the interaction between Ipratropium-salbutamol and Prochlorperazine?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine changes needed; monitor ECG and potassium if high-dose salbutamol is used or other QT risk factors exist.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in